Section 1847A(i)(5) of the Act requires that for Part B rebatable drugs, as defined in section 1847A(i)(2)(A) of the Act, furnished on or after April 1, 2023, in quarters in which the payment amount described in section 1847A(i)(3)(A)(ii)(I) of the Act (or, in the case of selected drugs described under section 1192(c) of the Act, the payment amount described in section 1847A(b)(1)(B) of the Act), exceeds the inflation-adjusted payment amount determined in accordance with section 1847A(i)(3)(C) of the Act, the coinsurance will be 20 percent of the inflation-adjusted payment amount for such quarter (hereafter, the inflation-adjusted coinsurance amount)
Before anything was prescribed, she completed an online assessment that included questions about her physical and mental health, lifestyle habits, challenges, and goals
When the new GLP-1 drugs come off the list, compounding pharmacies are supposed to stop selling semaglutide and tirzepatide, which will send many off-label patients scrambling for affordable medication
Nonsticky & nonstaining: Leaves no sticky residue or marks on clothes and doesnt clog pores